Margareta Linden
Corporate Officer/Principal bei University of Lund
Profil
Margareta Linden has been Senior Director of Project Planning and Development for Camurus AB since March 2004 and an Associate Professor of Experimental Respiratory Medicine at Lund University since 1993.
Previously, she held various positions at AstraZeneca AB.
Dr. Linden has more than 20 years of R&D and project management experience in the pharmaceutical industry.
She received a BS degree and a PhD from Lund University.
Aktive Positionen von Margareta Linden
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 01.01.1993 |
Ehemalige bekannte Positionen von Margareta Linden
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
| CAMURUS AB | Corporate Officer/Principal | - |
Ausbildung von Margareta Linden
| University of Lund | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAMURUS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
